Julien Beyrath

1.5k total citations
33 papers, 1.2k citations indexed

About

Julien Beyrath is a scholar working on Molecular Biology, Clinical Biochemistry and Immunology. According to data from OpenAlex, Julien Beyrath has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 5 papers in Immunology. Recurrent topics in Julien Beyrath's work include Mitochondrial Function and Pathology (18 papers), ATP Synthase and ATPases Research (10 papers) and Metabolism and Genetic Disorders (5 papers). Julien Beyrath is often cited by papers focused on Mitochondrial Function and Pathology (18 papers), ATP Synthase and ATPases Research (10 papers) and Metabolism and Genetic Disorders (5 papers). Julien Beyrath collaborates with scholars based in Netherlands, France and Germany. Julien Beyrath's co-authors include Jan Smeıtınk, Peter H.G.M. Willems, Werner J.H. Koopman, G. Herma Renkema, Sylvie Fournel, Richard J. Rodenburg, Saskia Koene, Gilles Guichard, Frans G. M. Rüssel and Mina Pellegrini and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Julien Beyrath

33 papers receiving 1.2k citations

Peers

Julien Beyrath
Ronald J. Holewinski United States
Kathryn E. Kronquist United States
Nils Burger United Kingdom
Tatiana Sheiko United States
Sean T. Bailey United States
Julien Beyrath
Citations per year, relative to Julien Beyrath Julien Beyrath (= 1×) peers Yanling Yang

Countries citing papers authored by Julien Beyrath

Since Specialization
Citations

This map shows the geographic impact of Julien Beyrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Beyrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Beyrath more than expected).

Fields of papers citing papers by Julien Beyrath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Beyrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Beyrath. The network helps show where Julien Beyrath may publish in the future.

Co-authorship network of co-authors of Julien Beyrath

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Beyrath. A scholar is included among the top collaborators of Julien Beyrath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Beyrath. Julien Beyrath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xiaoying, G. Herma Renkema, Johannes C. Schoeman, et al.. (2021). Mechanism of action and potential applications of selective inhibition of microsomal prostaglandin E synthase-1-mediated PGE2 biosynthesis by sonlicromanol’s metabolite KH176m. Scientific Reports. 11(1). 880–880. 19 indexed citations
2.
Lopes, Fernanda Martins, Monika A. Myszczynska, Elizabeth J. New, et al.. (2020). Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons. Scientific Reports. 10(1). 15485–15485. 18 indexed citations
3.
Renkema, G. Herma, et al.. (2019). A Drosophila Mitochondrial Complex I Deficiency Phenotype Array. Frontiers in Genetics. 10. 245–245. 11 indexed citations
4.
Smeıtınk, Jan, Saskia Koene, Julien Beyrath, et al.. (2019). Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients. JIMD Reports. 46(1). 52–62. 16 indexed citations
5.
Prigione, Alessandro, et al.. (2019). Live-Imaging Readouts and Cell Models for Phenotypic Profiling of Mitochondrial Function. Frontiers in Genetics. 10. 131–131. 18 indexed citations
6.
Beyrath, Julien, Mina Pellegrini, G. Herma Renkema, et al.. (2018). KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery. Scientific Reports. 8(1). 6577–6577. 57 indexed citations
7.
Smeıtınk, Jan, et al.. (2018). Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD+. Cell Death and Disease. 9(11). 1135–1135. 29 indexed citations
8.
Haas, Ria de, Devashish Das, Alejandro Garanto, et al.. (2017). Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease. Scientific Reports. 7(1). 11733–11733. 34 indexed citations
9.
Koene, Saskia, Edwin Spaans, Luc Van Bortel, et al.. (2017). KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers. Orphanet Journal of Rare Diseases. 12(1). 163–163. 43 indexed citations
10.
Smeıtınk, Jan, et al.. (2016). Multiplexed high-content analysis of mitochondrial morphofunction using live-cell microscopy. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1857. e124–e124. 2 indexed citations
11.
Smeıtınk, Jan, et al.. (2016). Multiplexed high-content analysis of mitochondrial morphofunction using live-cell microscopy. Nature Protocols. 11(9). 1693–1710. 72 indexed citations
12.
Koopman, Werner J.H., Julien Beyrath, Cheuk‐Wing Fung, et al.. (2016). Mitochondrial disorders in children: toward development of small‐molecule treatment strategies. EMBO Molecular Medicine. 8(4). 311–327. 71 indexed citations
13.
Schirris, Tom J.J., G. Herma Renkema, Tina Ritschel, et al.. (2015). Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition. Cell Metabolism. 22(3). 399–407. 169 indexed citations
14.
Willems, Peter H.G.M., et al.. (2015). Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeutics. The International Journal of Biochemistry & Cell Biology. 63. 60–65. 18 indexed citations
15.
Smulski, Cristian R., Julien Beyrath, Marion Décossas, et al.. (2013). Cysteine-rich Domain 1 of CD40 Mediates Receptor Self-assembly. Journal of Biological Chemistry. 288(15). 10914–10922. 28 indexed citations
16.
Destouches, Damien, Nicolas Pagé, Yamina Hamma‐Kourbali, et al.. (2011). A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface Nucleoproteins. Cancer Research. 71(9). 3296–3305. 83 indexed citations
17.
Pavet, Valeria, Julien Beyrath, Christophe Pardin, et al.. (2010). Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity. Cancer Research. 70(3). 1101–1110. 89 indexed citations
18.
Weidner, Steffen M., et al.. (2010). Novel powerful water-soluble lipid immunoadjuvants inducing mouse dendritic cell maturation and B cell proliferation using TLR2 pathway. Bioorganic & Medicinal Chemistry Letters. 20(6). 1869–1872. 7 indexed citations
19.
Górska, Katarzyna, Julien Beyrath, Sylvie Fournel, Gilles Guichard, & Nicolas Winssinger. (2010). Ligand dimerization programmed by hybridization to study multimeric ligand–receptor interactions. Chemical Communications. 46(41). 7742–7742. 43 indexed citations
20.
Beyrath, Julien, et al.. (2008). Design and synthesis of intrinsically cell-penetrating nucleopeptides. Organic & Biomolecular Chemistry. 6(20). 3661–3661. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026